Using the industry peer median P/E Multiples multiple (trailing + forward), Spire Global, Inc. (SPIR) has a fair value of $0.01 based on 5 comparable companies in the Specialty Business Services industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| Spire Global, Inc.SPIR | 515,687 | 10.8x | — |
| Acacia Research Corporation | 450 | 21.2x | — |
| Quad/Graphics, Inc. | 395 | 14.2x | — |
| ACCO Brands Corporation | 373 | 9.2x | — |
| SBC Medical Group Holdings Incorporated | 329 | 6.4x | 5.4x |
| Wabash National Corporation | 317 | 1.5x | 2.3x |
| Industry Median | 9.2x | 3.9x | |
| (*) Profit after tax | 51 | ||
| Equity Value | 471 | ||
| (/) Outstanding shares | 31,951 | ||
| Fair Price | $0 | ||
Using the industry peer median EV/Revenue multiple (trailing + forward), Spire Global, Inc. (SPIR) has a fair value of $0.50 based on 10 comparable companies in the Specialty Business Services industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Spire Global, Inc.SPIR | 515,687 | 6982.6x | 4659.7x |
| Costamare Bulkers Holdings Ltd | 468 | 0.7x | — |
| Acacia Research Corporation | 450 | 0.9x | 4.3x |
| Quad/Graphics, Inc. | 395 | 0.3x | 0.3x |
| Civeo Corporation | 394 | 0.9x | 0.8x |
| ACCO Brands Corporation | 373 | 0.8x | 0.7x |
| SBC Medical Group Holdings Incorporated | 329 | 1.3x | 1.0x |
| Wabash National Corporation | 317 | 0.5x | 0.3x |
| flyExclusive, Inc. | 190 | 1.1x | 1.2x |
| JELD-WEN Holding, Inc. | 146 | 0.5x | 0.4x |
| Rich Sparkle Holdings Limited Ordinary Shares | 90 | 13.9x | — |
| Industry Median | 0.8x | 0.8x | |
| (*) Revenue | 72 | 107 | |
| = Enterprise Value | 59 | 82 | |
| (-) Net Debt | -16,058 | -16,058 | |
| Equity Value | 16,117 | 16,140 | |
| (/) Outstanding shares | 31,951 | 31,951 | |
| Fair Price | $1 | $1 | |
Using the PEG framework with historical EPS growth of 8.0%, the company has a fair value of $11.92 based on TTM EPS (FY2025) of $1.49.
| EPS Growth RateHistorical | 0.0% |
| Adjusted Growth (clamped 8–25%)Clamped | 8.0% |
| Fair P/E | 8.0x |
| TTM EPS (FY2025) | $1.49 |
| Fair Value | $11.92 |
No analyst estimates available.
| Year | Net Income | EPS | YoY |
|---|---|---|---|
| FY2021 | $-38.1M | $-4.90 | — |
| FY2022 | $-99.0M | $-5.66 | — |
| FY2023 | $-77.6M | $-3.96 | — |
| FY2024 | $-102.8M | $-4.26 | — |
| FY2025 | $51.3M | $1.49 | — |
4Y Historical EPS CAGR: 0.0%
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.